Your browser doesn't support javascript.
loading
Re: 'Is a randomized trial of a short course of aminoglycoside added to ß-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?' Pharmacokinetic/pharmacodynamic considerations.
Heffernan, A; Lipman, J; Roberts, J.
Affiliation
  • Heffernan A; School of Medicine, Griffith University, Gold Coast, Qld, Australia; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, University of Queensland, Brisbane, Qld, Australia.
  • Lipman J; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia; Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia.
  • Roberts J; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia; Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia. Electronic address: j.roberts2@uq.edu.au.
Clin Microbiol Infect ; 24(6): 666-667, 2018 06.
Article in En | MEDLINE | ID: mdl-29309932
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness / Aminoglycosides Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Microbiol Infect Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness / Aminoglycosides Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Microbiol Infect Year: 2018 Document type: Article